Previous studies have shown that GLE suppresses BC cell growth and metastatic potential by inhibiting pro-invasive genes, transcriptional activators, and key signaling pathways, including urokinase-type plasminogen activator (uPA) and its receptor uPAR [21,26,27,28,29]. Here, PLAU is linked to breast cancer.